1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Inhibikase Therapeutics, Inc.

Inhibikase Therapeutics, Inc.

IKT
Inhibikase Therapeutics, Inc.US flagNASDAQ
2.04
USD
-0.03
- -
269.35MMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
2
6
3
15
18
20
29
53
+ Selling, General & Admin
3
4
3
7
6
7
11
24
+ Research & Development
4
3
1
11
12
14
17
30
+ Other Operating Expense
-4
-1
-1
-3
- -
- -
- -
- -
Operating Income (Loss)
-2
-6
-3
-15
-18
-20
-29
-53
- Non-Operating (Income) Loss
- -
- -
- -
- -
- -
-1
-1
-5
+ Interest Expense, Net
- -
- -
- -
- -
- -
-1
-1
-4
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
1
1
4
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
-1
Pretax Income
-2
-6
-3
-15
-18
-19
-28
-48
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-2
-6
-3
-15
-18
-19
-28
-48
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-2
-6
-3
-15
-18
-19
-28
-48
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-2
-6
-3
-15
-18
-19
-28
-48
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-2
-6
-3
-15
-18
-19
-28
-48
EBIT
-2
-6
-3
-15
-18
-20
-29
-53
EBITDA
-2
-6
-3
-15
-18
-20
-29
-53
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-2
-6
-3
-15
-18
-20
-29
-53
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
2
2
1
3
4
6
24
98
Basic EPS, GAAP
-1.29
-3.42
-2.08
-4.87
-4.28
-3.16
-1.16
-0.49
Basic EPS from Cont Ops
-1.29
-3.42
-2.08
-4.87
-4.28
-3.16
-1.16
-0.49
Diluted Weighted Avg Shares
2
2
1
3
4
6
24
98
Diluted EPS, GAAP
-1.29
-3.42
-2.08
-4.87
-4.28
-3.16
-1.16
-0.49
Diluted EPS from Cont Ops
-1.29
-3.42
-2.08
-4.87
-4.28
-3.16
-1.16
-0.49

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
1
- -
15
42
24
14
98
180
+ Cash, Cash Equivalents & STI
- -
- -
14
41
23
13
98
179
+ Cash & Cash Equivalents
- -
- -
14
41
7
9
56
139
+ ST Investments
- -
- -
- -
- -
16
4
41
40
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
1
2
1
1
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
2
- -
- -
- -
1
- -
- -
1
+ Property, Plant & Equip, Net
- -
- -
- -
- -
1
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
1
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
2
- -
- -
- -
- -
- -
- -
1
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
2
- -
- -
- -
- -
- -
- -
1
Total Assets
3
- -
15
42
25
15
99
181
+ Payables & Accruals
3
3
2
3
3
3
3
2
+ Accounts Payable
1
1
2
1
1
1
1
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
2
1
2
2
2
2
1
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
1
2
- -
- -
1
1
6
+ Deferred Revenue
- -
1
2
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
1
1
6
Total Current Liabilities
4
4
5
4
4
3
4
8
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
Total Liabilities
4
5
5
4
4
4
4
8
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
6
8
25
68
69
78
189
316
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
6
8
25
68
69
78
189
315
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-6
-12
-15
-30
-48
-67
-94
-143
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-1
-4
10
38
21
11
95
173
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-1
-4
10
38
21
11
95
173
Total Liabilities & Equity
3
- -
15
42
25
15
99
181
Shares Outstanding
2
2
2
4
4
6
69
132
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
- -
- -
-14
-41
-7
-9
-56
-139
Net Debt to Equity
18.74
-7.91
-139.35
-105.43
-34.17
-83.49
-59.55
-80.52
Tangible Common Equity Ratio
-27.33
-11,737.38
66.19
90.45
84.36
75.68
96.21
95.42
Current Ratio
0.35
0.01
3.13
10.47
6.59
4.13
26.37
21.7
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-2
-6
-3
-15
-18
-19
-28
-48
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
1
4
2
2
1
1
8
20
+ Stock-Based Compensation
1
1
1
2
- -
1
8
15
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
7
+ Other Non-Cash Adj
1
2
2
1
- -
- -
- -
-2
+ Chg in Non-Cash Work Cap
2
2
- -
-2
- -
- -
- -
- -
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
-1
- -
1
- -
-1
+ Inc (Dec) in Accts Payable
2
- -
-1
1
- -
-1
1
2
+ Inc (Dec) in Other
- -
1
1
-2
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
1
- -
-1
-14
-17
-18
-19
-28
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
1
- -
15
41
- -
9
103
108
+ Increase in Capital Stock
1
- -
15
41
- -
9
103
108
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
-16
12
-37
3
+ Dec in LT Investment
- -
- -
- -
- -
5
41
23
42
+ Inc in LT Investment
- -
- -
- -
- -
-21
-29
-60
-39
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
-16
12
-37
2
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
-2
- -
- -
- -
- -
- -
- -
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
- -
15
41
- -
8
103
108
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
14
27
-34
2
47
83
EBITDA
-2
-6
-3
-15
-18
-20
-29
-53
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
1
- -
-1
-14
-18
-18
-19
-28
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
- -
-1
-14
-18
-18
-19
-28
Free Cash Flow per Basic Share
0.43
-0.2
-0.83
-4.71
-4.17
-3
-0.81
-0.29
Price/Free Cash Flow
- -
- -
-50.18
-1.87
-0.74
-0.42
-4.02
-7.37
Cash Flow to Net Income
-0.33
0.06
0.4
0.97
0.96
0.95
0.7
0.58
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -